Now I have a thorough understanding of the paper and the calibrations. Let me write the final consolidated review.

---

## Summary

This paper introduces HypoGeneAgent, an LLM-driven framework that uses GPT-o3 to generate GO-based functional hypotheses for gene clusters from Perturb-seq data, then computes a Resolution Score (combining intra-cluster agreement ICS and inter-cluster distinctiveness ICD) to automatically select the optimal Leiden clustering resolution. Applied to a K562 CRISPRi Perturb-seq dataset, the method selects resolution 0.4 for gene-expression clusters and 0.5 for perturbation-level clusters—choices that are supported by functional enrichment analysis and differ from those suggested by traditional metrics (silhouette score, modularity). The paper also contributes a systematic Stage 1 benchmark comparing LLM backends, prompt designs, and embedding methods on 100 curated GOBP gene sets.

## Strengths

- **Novel formulation of resolution selection as a functional-annotation-consistency optimization**: The core idea—feeding LLM-generated functional annotations back into clustering hyperparameter selection—is genuinely novel and addresses a real problem in single-cell analysis. Prior work uses LLMs for post-hoc annotation only; this paper closes the loop between unsupervised partitioning and biological interpretation. Section 1 and Section 3.4 formalize this clearly.

- **Clean decomposition of annotation quality into ICS and ICD**: The paper defines Intra-Cluster Similarity (agreement among hypotheses for the same cluster) and Inter-Cluster Distinctiveness (separation between clusters' top hypotheses), then combines them into a single Resolution Score. This decomposition is conceptually principled, model-agnostic, and could be reused by future work. See Table 1 and Section 3.4.

- **Systematic Stage 1 ablation on GOBP gene sets**: The paper benchmarks multiple LLMs (GPT-o3, GPT-4o, Gemini-2.5-pro, etc.), embedding methods (OpenAI, SapBERT, Nomic), and prompt designs (general vs. hypothesis prompts). The finding that thinking LLMs (GPT-o3) with hypothesis prompts achieve the best cosine similarity to ground truth, and that the model's self-confidence correlates with semantic accuracy (AUC=0.743), provides useful empirical guidance for practitioners deploying LLMs for gene-set annotation. Figures S1–S3 document this thoroughly.

## Weaknesses

### Fatal
None.

### Major
- **The resolution selection lacks a direct head-to-head biological comparison against alternatives selected by traditional metrics.** The paper shows that silhouette (r=0.5/0.6) and modularity (r=0.7) pick different optimal resolutions than HypoGeneAgent (r=0.4 GEX, r=0.5 perturbation), and validates that HypoGeneAgent's pick yields biologically coherent clusters via GO enrichment analysis. However, it does not quantitatively compare whether clusters at r=0.4 recover *more* known biology—more significant enrichment terms, better correspondence with known cell types or perturbation categories—than clusters at r=0.7 (modularity's optimum) or r=0.5/0.6 (silhouette's optimum). The enrichment analysis (Section 4.4.3, Figure 6) is the right type of evidence but compares resolutions using the same ICS/ICD metric framework (albeit on independent Fisher-exact enrichment outputs), rather than against an external ground-truth standard such as known K562 cell types or held-out pathway annotations. The paper's central claim is that the Resolution Score selects *better* resolutions, not just *different* ones, and the current evidence is insufficient to substantiate the "better" claim with the rigor it requires.

### Minor
- **The sensitivity of the Resolution Score to the weight parameter w is not reported.** The paper states (Section 3.4) that w=1/3 was chosen by "a small grid search and found to give a stable ordering of resolutions across data sets," but shows none of the grid search results. A figure showing how the optimal resolution changes as w varies from 0 to 1 (relegated to Figure S5 in the appendix, which the parser stripped) would be important for establishing the method's robustness. As it stands, the reader cannot assess whether the resolution choice is sensitive to this hyperparameter.

- **Statistical significance of resolution differences is not reported.** The box plots in Figures 3–4 show overlapping distributions across neighboring resolutions. The paper selects r=0.4 based on the highest median Resolution Score, but does not report whether the difference between r=0.4 and r=0.5 (or r=0.6) is statistically significant via permutation test, bootstrapping, or any other method. With small numbers of clusters at each resolution, these differences could arise from noise.

- **Stage 1 validation on curated GOBP sets may not fully transfer to real Perturb-seq clusters.** The Stage 1 benchmark uses 100 clean, non-redundant GOBP gene sets with well-established ground-truth annotations. Real Perturb-seq cluster signatures are noisier, contain hundreds of genes, and represent mixed cell states. The paper would be strengthened by a small case study showing that the LLM's top-1 hypothesis for, say, 5–10 specific K562 clusters is verifiably correct when compared against known biology (e.g., marker genes or published annotations). This would bridge the gap between the clean benchmark evaluation and the real-data application.

### Trivial
- Some figures referenced in the text (Figures S1–S6) are in the appendix that was stripped during parsing; the main text's verbal summaries of these results are somewhat vague (e.g., "thinking LLMs perform better than non-thinking LLMs").
- The term "HypoGeneAgent referee panel score" is introduced but never clearly defined as distinct from the Resolution Score.

## Nice-to-Haves

- An ablation replacing GPT-o3 with a simpler (cheaper) model like GPT-4o-mini or Gemini-flash to test whether the Resolution Score's resolution choice is robust to the LLM backbone. This would help users understand the method's cost-performance trade-off.
- A brief analysis of how computational cost (API calls, time, dollar cost) scales with dataset size, to help practitioners assess feasibility.
- A discussion of failure modes: what happens when the LLM generates incorrect but internally consistent hypotheses (inflating ICS artificially)?

## Removed Points

These points from the input reviews are flagged for removal; treat them with caution.

1. **"Zero quantitative evidence"** — The critique that the paper provides *zero* quantitative evidence is an overstatement. Section 4.4.3 provides quantitative GO enrichment analysis (Fisher-exact test, an independent method) across resolutions, and the results support the selected resolution. The evidence is incomplete (missing head-to-head biological comparison), not absent.

2. **"Circular validation"** — The enrichment analysis uses standard Fisher-exact testing (a completely different methodology from the LLM annotation) to find enriched GO terms per cluster at each resolution. Applying ICS/ICD metrics to these independent enrichment results is a measurement framework, not circular logic. However, using the same metrics does limit the independence of the validation, which is why this is retained as a minor concern rather than removed entirely.

3. **Formatting nitpicks, missing appendix content, reproducibility micro-details** — Removed per the hard rules about parser artifacts and reproducibility nitpicks.

4. **Generic strengths about "addressing an important problem"** — Removed from the Strength Finder output; only specific, evidence-backed strengths are retained.

5. **"Stage 1 benchmark is a strength"** — Retained because it is specific and evidenced by Figures S1–S3 and Section 4.3. This is a genuine contribution.

6. **Strength Finder's claim about "Empirical demonstration that the Resolution Score outperforms traditional metrics"** — This is partially retained in modified form (it shows that different metrics pick different resolutions and that the chosen resolution is supported by enrichment analysis) but weakened because the paper doesn't directly demonstrate *outperformance* in a head-to-head biological comparison.

## Novel Insights

The most interesting observation from the reviews is the fundamental tension the paper surfaces: it attempts to ground an unsupervised clustering hyperparameter in biological interpretability, but then evaluates that grounding using a metric derived from the same LLM that defined "interpretability" in the first place. This is not a fatal flaw—the enrichment analysis provides an independent anchor—but it highlights a deeper challenge for the field: how to close the loop between data-driven clustering and biological validation without circularity. The paper's clean decomposition (ICS/ICD) is a step in the right direction, but the community will ultimately need held-out biological ground truth (e.g., known cell types, validated pathway annotations) as independent benchmarks, a step the paper does not fully take. The systemic Stage 1 benchmark comparing LLMs and prompts for gene-set annotation is also a practically useful resource that future work can build on.

## Suggestions

1. **Add a head-to-head biological comparison across resolutions.** Use the same GO enrichment analysis pipeline to compare the number of significant terms (padj < 0.05), enrichment specificity, or overlap with known K562 biology at HypoGeneAgent's selected resolution (r=0.4) versus modularity's selected resolution (r=0.7) and silhouette's selected resolution (r=0.5/0.6). If the paper can show that r=0.4 yields more or better enrichment terms, the central claim would be substantially stronger.

2. **Report the w-parameter sensitivity analysis** (from Figure S5) in the main paper, showing that the optimal resolution choice is stable across a range of w values.

3. **Add a small case study** annotating 5–10 K562 clusters at the selected resolution with known biological functions from the literature, to directly validate that the LLM's hypotheses (which drive the Resolution Score) are factually correct for this specific dataset.

4. **Report statistical significance** (e.g., bootstrap confidence intervals for the median Resolution Score at each resolution) to rule out the possibility that the apparent optimal resolution is an artifact of small sample size.

## Score and Decision

### Calibration Anchors

| Anchor Path | Avg Score | Comparison |
|---|---|---|
| `/home/wg25r/review_agent/human_reviews_2026/pYlM1pt92v.md` | 3.50 (Reject) | LLMs + single-cell — that paper had a fundamentally flawed evaluation (apples-to-oranges comparison); this paper's evaluation is more honest but less comprehensive. This paper is somewhat stronger. |
| `/home/wg25r/review_agent/human_reviews_2026/uA8BcIuZc4.md` | 4.67 (Reject) | Efficient scFM — solid empirical work with comprehensive evaluation across 8 datasets, but incremental architecture. This paper has more novelty but less thorough validation. Comparable quality. |
| `/home/wg25r/review_agent/human_reviews_2026/zxlbh55PhC.md` | 5.33 (Accept) | Single-cell clustering diffusion — clean method with synthetic + real data evaluation. This paper has a more novel contribution but weaker validation. Slightly weaker overall. |
| `/home/wg25r/review_agent/human_reviews_2026/4UY1NHG5Ge.md` | 4.00 (Accept) | Genomic FM evaluation — thorough benchmarking study across 52 tasks. More rigorous evaluation but less novelty. Comparable. |
| `/home/wg25r/review_agent/human_reviews_2026/RDerF20JYT.md` | 8.00 (Accept) | Protein generation — SOTA results, strong method, multiple benchmarks. Far stronger paper than this one. |
| `/home/wg25r/review_agent/human_reviews_2026/uTderO7iyk.md` | 3.00 (Withdrawn) | LLM for perturbation prediction — limited validation, modest results. This paper is stronger. |
| `/home/wg25r/review_agent/human_reviews_2026/lYp3tNTgpE.md` | 4.00 (Reject) | Causal discovery in Perturb-seq — reasonable method but limited novelty. Comparable. |

The paper's core idea is genuinely novel and well-motivated, and the Stage 1 ablation provides a useful practical contribution. However, the main claim (that the Resolution Score selects *biologically better* resolutions) is not fully substantiated: there is no direct head-to-head biological comparison showing that clusters at the selected resolution outperform clusters at alternative resolutions chosen by traditional metrics. This weakness is real but not fatal—the paper provides enrichment-based validation and the core framework is independently valuable. Comparable papers in this space at ICLR 2026 cluster around scores of 3.5–5.3, with this paper sitting in the upper middle of that range.

**Score: 4.5**

**Decision: Reject**

MY FINAL SCORE: <pineapple>4.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>